In den Warenkorb
Bestellen Sie auch über:
 |
+49 (0)241 95 163 153 |
 |
+49 (0)241 95 163 155 |
Indoleamine 2,3-Dioxygenase (IDO) Antikörper
| Antigen | Indoleamine 2,3-Dioxygenase (IDO) |
| Klonalität | Monoklonal |
| Wirt |
Maus |
| Reaktivität |
Human |
| Applikation |
ELISA
|
 |
2 Publikationen vorhanden |
| Produktnummer | ABIN334652 |
| Menge | 100ug |
| Preis | 362,50 € Zzgl. Versandkosten €20,00 und MWSt |
| Lieferung nach |
|
| Verfügbarkeit | Lieferung in 10 Werktagen |
Produktbeschreibung
| Immunogen | IDO-MCA was derived from hybridoma produced by the fusion of mouse myeloma cells and spleenocytes from immunized mice. IDO-MCA was isolated from culture supernatant (serum free) of hybridoma by Protein G affinity chromatography. |
| Format | Affinity-purified |
| Isotyp | IgG1 (Passende Sekundärantikörper) |
| Spezifität | React with recombinant human IDO expressed by 293 cells |
Anwendungen
| Reinheit | >95% by SDS-PAGE analysis |
| Buffer | 1 mg/mL (Phosphate buffered saline (PBS) pH 7.4, 0.05% NaN3) |
| Lagerung | Store below -20 degree Celsius |
| Beschränkungen | Nur für Forschungszwecke einsetzbar |
Publikationen
| Publikationen |
Takikawa, Kuroiwa, Yamazaki et al.: "Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity." in: The Journal of biological chemistry, Vol. 263, Issue 4, pp. 2041-8, 1988 (PubMed).
Ino, Yoshida, Kajiyama et al.: "Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer." in: British journal of cancer, Vol. 95, Issue 11, pp. 1555-61, 2006 (PubMed). |
